Reporting Manager
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Symbol
FBRX
Shares outstanding
12,693,554 shares
Disclosed Ownership
1,268,086 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
04 Aug 2025, 18:21:26 UTC
Date of event
30 Jun 2025
Previous filing
14 Feb 2025

Sponsored

Quoteable Key Fact

"TYBOURNE CAPITAL MANAGEMENT (HK) LTD disclosed 10% ownership in Forte Biosciences, Inc. Common Stock (FBRX) on 30 Jun 2025."

Quick Takeaways

  • TYBOURNE CAPITAL MANAGEMENT (HK) LTD filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock (FBRX).
  • Disclosed ownership: 10%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 04 Aug 2025, 18:21.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% 1,268,086 0 1,268,086 /s/ Charlotte Fung Charlotte Fung, Chief Financial Officer
TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Director
Tybourne Capital Management Ltd 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Principal
Tybourne Kesari Ltd 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Principal
Krishnan Viswanathan 10% 1,268,086 0 1,268,086 /s/ Viswanathan Krishnan Viswanathan Krishnan, Individually